Search Within

Chaitanya Divgi

  1. "Hematologic Malignancies, Division of"
Formats
  1. Journal Article (18)
  2. Meeting Abstract (16)
  3. Conference Paper (2)
  4. Book Section (1)
Groups
  1. Department of Medicine (37)
  2. Hematologic Malignancies, Division of (37)
  3. Molecular Imaging and Therapy Service (35)
  4. Radiology, Department of (35)
  5. Center for Hematologic Malignancies (33)
  6. GSK Faculty (31)

More Groups

People
  1. Steven Larson (30)
  2. Ronald Finn (25)
  3. David Scheinberg (24)
  4. George Sgouros (17)
  5. Joseph Jurcic (12)
  6. Neeta Pandit-Taskar (12)

More People

Years
  1. 2011 (1)
  2. 2010 (1)
  3. 2007 (2)
  4. 2006 (2)
  5. 2005 (3)
  6. 2004 (2)

More Years

Publications
  1. Blood (7)
  2. Journal of Nuclear Medicine (7)
  3. Journal of Clinical Oncology (5)
  4. Clinical Cancer Research (4)
  5. Cancer Biotherapy and Radiopharmaceuticals (3)
  6. Cancer (2)

More Publications

Publishers
  1. American Society of Hematology (7)
  2. Society of Nuclear Medicine (7)
  3. American Association for Cancer Research (5)
  4. American Society of Clinical Oncology (5)
  5. Mary Ann Liebert, Inc (3)
  6. Wiley Blackwell (2)

More Publishers

Results (37)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • (124)I-huA33 antibody PET of colorectal cancer
    Journal Article

    Carrasquillo, J. A.; Pandit-Taskar, N.; O'Donoghue, J. A.; Humm, J. L.; Zanzonico, P.; Smith-Jones, P. M.; Divgi, C. R.; Pryma, D. A.; Ruan, S.; Kemeny, N. E.; more...
    Journal of Nuclear Medicine (2011)

    Fulltext@MSK | Save
  • Sequential cytarabine and α-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia
    Journal Article

    Rosenblat, T. L.; McDevitt, M. R.; Mulford, D. A.; Pandit-Taskar, N.; Divgi, C. R.; Panageas, K. S.; Heaney, M. L.; Chanel, S.; Morgenstern, A.; Sgouros, G.; more...
    Clinical Cancer Research (2010)

    Fulltext@MSK | Save
  • Phase I evaluation of J591 as a vascular targeting agent in progressive solid tumors
    Journal Article

    Morris, M. J.; Pandit-Taskar, N.; Divgi, C. R.; Bender, S.; O'Donoghue, J. A.; Nacca, A.; Smith-Jones, P.; Schwartz, L.; Slovin, S.; Finn, R.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • Study of radiolabeled indium-111 and yttrium-90 ibritumomab tiuxetan in primary central nervous system lymphoma
    Journal Article

    Iwamoto, F. M.; Schwartz, J.; Pandit-Taskar, N.; Peak, S.; Divgi, C. R.; Zelenetz, A. D.; Humm, J.; Abrey, L. E.
    Cancer (2007)

    Fulltext@MSK | Save
  • Sequential radioimmunotherapy with tositumomab/iodine I131 tositumomab followed by CHOP for mantle cell lymphoma demonstrates RIT can induce molecular remissions
    Meeting Abstract

    Zelenetz, A. D.; Noy, A.; Pandit-Taskar, N.; Scordo, M.; Rijo, I.; Zhou, Y.; O'Donoghue, J. A.; Divgi, C.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Alpha-particle immunotherapy for acute myeloid leukemia (AML) with bismuth-213 and actinium-225
    Meeting Abstract

    Jurcic, J. G.; McDevitt, M. R.; Pandit-Taskar, N.; Divgi, C. R.; Finn, R. D.; Sgouros, G.; Apostalidis, C.; Chanel, S.; Larson, S. M.; Scheinberg, D. A.
    Cancer Biotherapy and Radiopharmaceuticals (2006)

    Fulltext@MSK | Save
  • Sequential radioimmunotherapy with tositumomab/iodine I131 tositumomab followed by CHOP chemotherapy for mantle cell lymphoma is a safe and highly effective regimen
    Meeting Abstract

    Zelenetz, A.; Donnelly, G.; Pandit-Taskar, N.; Humm, J.; Divgi, C.
    Annals of Oncology (2005)

    Fulltext@MSK | Save
  • Early safety and efficacy analysis of a phase II study of sequential R-CHOP and Yttrium-90 ibritumomab tiuxetan (Zevalin((R))) for elderly high risk patients with untreated DLBCL
    Meeting Abstract

    Hamlin, P. A.; Moskowitz, C. H.; Wegner, B. C.; Portlock, C. S.; Straus, D. J.; Noy, A.; Dumitrescu, O.; Palomba, M. L.; Horwitz, S. M.; O'Connor, O. A.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • Pilot trial of unlabeled and indium-111-labeled anti-prostate-specific membrane antigen antibody J591 for castrate metastatic prostate cancer
    Journal Article

    Morris, M. J.; Divgi, C. R.; Pandit-Taskar, N.; Batraki, M.; Warren, N.; Nacca, A.; Smith-Jones, P.; Schwartz, L.; Kelly, W. K.; Slovin, S.; more...
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save
  • Sequential therapy with cytarabine and bismuth-213 (Bi-213)-labeled-HuM195 (anti-CD33) for acute myeloid leukemia (AML)
    Meeting Abstract

    Mulford, D. A.; Pandit-Taskar, N.; McDevitt, M. R.; Finn, R. D.; Weiss, M. A.; Apostolidis, C.; Morgenstern, A.; Divgi, C. R.; Larson, S. M.; Scheinberg, D. A.; more...
    Blood (2004)

    Fulltext@MSK | Save